Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
190 studies found for:    puberty
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Delayed Puberty in Boys; Clinical and Biochemical Characteristics and Effect of Testosterone Treatment
Condition: Delayed Puberty
Intervention: Other: retrospective data collection
2 Completed Follicle-Stimulating Hormone (FSH) and the Onset of Puberty
Conditions: Delayed Puberty;   Precocious Puberty
Interventions: Drug: Leuprolide Acetate - Early Puberty Leuprolide Visit;   Drug: Ganirelix - Early Puberty Ganirelix Visit;   Drug: Ganirelix - Delayed Puberty Ganirelix Visit;   Drug: Leuprolide Acetate- Delayed Puberty Leuprolide Visit
3 Unknown  Markers of Pubertal Suppression During Therapy for Precocious Puberty
Condition: Central Precocious Puberty
Intervention:
4 Unknown  Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children
Condition: Central Precocious Puberty
Interventions: Drug: Triptorelin (GnRH agonists);   Drug: Leuprolide (GnRH agonists)
5 Completed Psychosocial Impact of Early Puberty in Girls Aged 6 to 8 Years
Condition: Early Puberty
Intervention:
6 Enrolling by invitation Long-term Outcome of GnRH Analogues Treatment of Children With Idiopathic Central Precocious Puberty
Conditions: Puberty, Precocious;   Adiposity
Intervention: Other: GnRHas
7 Completed Treatment of Boys With Precocious Puberty
Condition: Precocious Puberty
Interventions: Drug: Spironolactone;   Drug: Testolactone;   Drug: Deslorelin
8 Unknown  First-Voided Urinary LH vs. GnRH-stimulation in Differentiating Slowly- From Rapidly Progressive-Precocious Puberty
Condition: Precocious Puberty, Gonadotropin-dependent
Interventions: Other: Measurement of LH in first-voided urine;   Other: collection of first-voided urine sample for LH level
9 Completed
Has Results
A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty
Condition: Puberty, Precocious
Interventions: Drug: Leuprolide acetate 11.25 mg;   Drug: Leuprolide acetate 30 mg
10 Completed
Has Results
Study of Lupron Depot In The Treatment of Central Precocious Puberty
Condition: Puberty, Precocious
Intervention: Drug: Lupron (leuprolide acetate)
11 Recruiting Constitutional Delay of Growth and Puberty: Towards Evidence-based Treatment
Condition: Constitutional Delay of Growth and Puberty
Interventions: Drug: Testosterone;   Drug: Letrozole
12 Unknown  Follow-up of Girls With Premature Thelarche and Precocious Puberty
Conditions: Precocious Puberty;   Excess; Development, Breast
Intervention:
13 Recruiting Effect of a GnRH Injection on Ghrelin Concentrations in Girls With Suspected Premature Puberty
Condition: Puberty, Precocious
Interventions: Drug: Gonadotropin releasing hormone (GnRH);   Drug: Sodium Chloride
14 Recruiting A Study to Assess the Safety and Efficacy of Leuprorelin in Central Precocious Puberty in Chinese Patients
Condition: Puberty, Precocious
Intervention: Drug: Leuprorelin
15 Completed Study of Comprehensive Diagnosis and Treatment for Children Precocious Puberty
Condition: Central Precocious Puberty
Interventions: Drug: Triptorlin or Leuprorelin;   Drug: Zhibo dihuang pills;   Drug: Dabu ying pills
16 Recruiting Analysis of Body Mass Index in Central Precocious Puberty Patients Treated With Leuprolide Acetate
Condition: Precocious Puberty, Central
Intervention: Drug: Leuprolide
17 Recruiting Clinical Trial of Experienced Chinese Herbal Formulas on Different Types of Precocious Puberty
Condition: Precocious Puberty
Interventions: Drug: ziyinxiehuo Granules;   Drug: zishenqinggan Granules
18 Completed
Has Results
Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty
Condition: Precocious Puberty
Intervention: Drug: Triptorelin pamoate 11.25mg (Decapeptyl® SR)
19 Completed Mexican and African American Family Focus Groups on Puberty
Condition: Healthy
Intervention: Behavioral: Focus Group
20 Recruiting Pharmacokinetic Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty
Condition: Precocious Puberty, Central
Intervention: Drug: Leuprolide Acetate 45 mg

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.